Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$5.67 - $8.06 $6,163 - $8,761
1,087 New
1,087 $7,000
Q4 2023

Jan 25, 2024

SELL
$3.61 - $7.76 $22,270 - $47,871
-6,169 Reduced 93.73%
413 $2,000
Q3 2023

Oct 27, 2023

BUY
$4.68 - $9.26 $30,803 - $60,949
6,582 New
6,582 $32,000
Q2 2023

Jul 18, 2023

SELL
$8.5 - $10.38 $1,105 - $1,349
-130 Reduced 2.11%
6,040 $55,000
Q1 2023

Apr 13, 2023

BUY
$7.53 - $10.95 $46,460 - $67,561
6,170 New
6,170 $58,000
Q2 2022

Jul 25, 2022

SELL
$6.99 - $10.0 $96,119 - $137,510
-13,751 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$7.26 - $10.7 $11,514 - $16,970
-1,586 Reduced 10.34%
13,751 $109,000
Q4 2021

Jan 28, 2022

BUY
$8.8 - $16.0 $134,965 - $245,392
15,337 New
15,337 $143,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $661M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.